Trial record 1 of 1 for:
IRB00179194
Therapy for High-Risk HPV 16-Positive Oropharynx Cancer Patients
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04001413 |
Recruitment Status :
Withdrawn
(Sponsor withdrew funding)
First Posted : June 28, 2019
Last Update Posted : July 29, 2022
|
Sponsor:
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Collaborator:
AstraZeneca
Information provided by (Responsible Party):
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
Recruitment Status : | Withdrawn |
---|---|
Actual Primary Completion Date : | March 25, 2021 |
Actual Study Completion Date : | March 25, 2021 |